|
2004 Conference Publication Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, AustraliaNissen, L. M., Cooke, C., Sketris, I. and Tett, S.E. (2004). Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
|
2004 Journal Article Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detectionAtcheson, Bronwyn, Taylor, Paul J., Mudge, David W., Johnson, David W., Pillans, Peter I. and Tett, Susan E. (2004). Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. Journal of Chromatography B, 799 (1), 157-163. doi: 10.1016/j.jchromb.2003.10.033 |
|
2004 Conference Publication Sample medication: What do Australian general practitioners think?Nissen, L. M., Hall, K. H. and Tett, S. E. (2004). Sample medication: What do Australian general practitioners think?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service. |
|
2004 Conference Publication An argument for dose individualisation of sirolimus in renal transplant recipientsDansirikul, C., Duffull, S. B., Morris, R. and Tett, S.E. (2004). An argument for dose individualisation of sirolimus in renal transplant recipients. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.v31_i11_abs.x |
|
2004 Journal Article A perspective on Australia's national medicines policyTett, S. E. (2004). A perspective on Australia's national medicines policy. Canadian Journal of Clinical Pharmacology, 11 (1), e28-e38. doi: 10.22374/jptcp.v11i1.62 |
|
2004 Conference Publication How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reportingChan, V. and Tett, S. E. (2004). How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service. |
|
2004 Conference Publication Bayesian population pharmacokinetic analysis of sirolimusDansirikul, C., Friberg, L. E., Duffull, S. B., Morris, R. and Tett, S.E. (2004). Bayesian population pharmacokinetic analysis of sirolimus. Population Approach Group in Europe - Thirteenth Meeting (PAGE), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University. |
|
2004 Journal Article Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatographyChan, V., Charles, B. G. and Tett, S. E. (2004). Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. Journal of Chromatography B-analytical Technologies In The Biomedical And Life Sciences, 803 (2), 331-335. doi: 10.1016/j.jchromb.2004.01.016 |
|
2004 Journal Article Sampling times for monitoring tacrolimus in stable adult liver transplant recipientsDansirikul, C, Staatz, CE, Duffull, SB, Taylor, PJ, Lynch, SV and Tett, SE (2004). Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Therapeutic Drug Monitoring, 26 (6), 593-599. doi: 10.1097/00007691-200412000-00003 |
|
2004 Conference Publication Do prescription medicine samples influence prescribing? Issues in Australian general practiceHall, K. H., Tett, S. E. and Nissen, L. M. (2004). Do prescription medicine samples influence prescribing? Issues in Australian general practice. Annual Conference of the APSA, 2004, Melbourne, Vic, Australia, 4-7 December, 2004. Mount Waverley, Victoria: Australasian Pharmaceutical Science Association. |
|
2004 Conference Publication Is cystatin-C a marker of renal function?Roos, J. F., Kirkpatrick, C. M. J. and Tett, S. E. (2004). Is cystatin-C a marker of renal function?. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
|
2003 Journal Article Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipientsWillis, Charlene, Staatz, Christine E. and Tett, Susan E. (2003). Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Therapeutic Drug Monitoring, 25 (2), 158-166. doi: 10.1097/00007691-200304000-00004 |
|
2003 Conference Publication Analysis of free mycophenolic acid and its glucuronide in human blood samplesAtcheson, B., Taylor, P. J. and Tett, S. E. (2003). Analysis of free mycophenolic acid and its glucuronide in human blood samples. IATDMCT Congress, Basel, Switzerland, September 2003. New York , U. S.: |
|
2003 Journal Article Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetilShum, B, Duffull, SB, Taylor, PJ and Tett, SE (2003). Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil. British Journal of Clinical Pharmacology, 56 (2003), 188-197. doi: 10.1046/j.1365-2125.2003.01863.x |
|
2003 Conference Publication Detecting drug interactions associated with tacrolimusStaatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Detecting drug interactions associated with tacrolimus. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney: |
|
2003 Journal Article Principles and clinical application of assessing alterations in renal elimination pathwaysTett, Susan E., Kirkpatrick, Carl M. J., Gross, Annette S. and McLachlan, Andrew J. (2003). Principles and clinical application of assessing alterations in renal elimination pathways. Clinical Pharmacokinetics, 42 (14), 1193-1211. doi: 10.2165/00003088-200342140-00002 |
|
2003 Journal Article Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban AustraliaCutts, Christopher and Tett, Susan E. (2003). Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia. European Journal of Clinical Pharmacology, 58 (11), 761-766. doi: 10.1007/s00228-002-0551-5 |
|
2003 Conference Publication Five year trends in HMG co-A reductase inhibitor use in Nova Scotia, Canada and Queensland, AustraliaCooke, C., Tett, S.E and Sketris, I. (2003). Five year trends in HMG co-A reductase inhibitor use in Nova Scotia, Canada and Queensland, Australia. Annual Conference of the Canadian Association for Population Therapeutics 2003, Quebec, 30 Mar. - 1 Apr. 2003. Canada: Pulsus. |
|
2003 Journal Article Prescription drug samples: Does this marketing strategy counteract policies for quality use of medicines?Groves, K. E. M., Sketris, I. and Tett, S. E. (2003). Prescription drug samples: Does this marketing strategy counteract policies for quality use of medicines?. Journal of Clinical Pharmacy And Therapeutics, 28 (4), 259-271. doi: 10.1046/j.1365-2710.2003.00481.x |
|
2003 Conference Publication Pharmacodynamic investigations of tacrolimus in liver transplantationStaatz, C. E., Dansirikul, C., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2003). Pharmacodynamic investigations of tacrolimus in liver transplantation. TSANZ 21st Annual Scientific Meeting, Canberra, 9-11 April 2003. Canberra: TSANZ. doi: 10.1046/j.1440-1711.2003.00812.x |
